Muoio, B.; Iacovitti, C.M.; Bosetti, D.G.; Sansovini, M.; Cuzzocrea, M.; Paone, G.; Treglia, G.
Peptide Receptor Radionuclide Therapy in Patients with Advanced, Recurrent or Progressive Meningioma: An Updated Systematic Review and Meta-Analysis. Cancers 2025, 17, 2039.
https://doi.org/10.3390/cancers17122039
AMA Style
Muoio B, Iacovitti CM, Bosetti DG, Sansovini M, Cuzzocrea M, Paone G, Treglia G.
Peptide Receptor Radionuclide Therapy in Patients with Advanced, Recurrent or Progressive Meningioma: An Updated Systematic Review and Meta-Analysis. Cancers. 2025; 17(12):2039.
https://doi.org/10.3390/cancers17122039
Chicago/Turabian Style
Muoio, Barbara, Cesare Michele Iacovitti, Davide Giovanni Bosetti, Maddalena Sansovini, Marco Cuzzocrea, Gaetano Paone, and Giorgio Treglia.
2025. "Peptide Receptor Radionuclide Therapy in Patients with Advanced, Recurrent or Progressive Meningioma: An Updated Systematic Review and Meta-Analysis" Cancers 17, no. 12: 2039.
https://doi.org/10.3390/cancers17122039
APA Style
Muoio, B., Iacovitti, C. M., Bosetti, D. G., Sansovini, M., Cuzzocrea, M., Paone, G., & Treglia, G.
(2025). Peptide Receptor Radionuclide Therapy in Patients with Advanced, Recurrent or Progressive Meningioma: An Updated Systematic Review and Meta-Analysis. Cancers, 17(12), 2039.
https://doi.org/10.3390/cancers17122039